Acrivon Therapeutics, Inc. Common Stock (ACRV) Volatility Skew

Implied volatility skew shows how IV varies across strike prices for a given expiration. Steeper skews indicate higher demand for downside protection relative to upside speculation.

Acrivon Therapeutics, Inc. Common Stock (ACRV) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $50.5M, listed on NASDAQ, employing roughly 75 people, carrying a beta of 2.02 to the broader market. Acrivon Therapeutics, Inc. Led by Peter Blume-Jensen, public since 2022-11-15.

Volatility skew analysis compares implied volatility across strikes and expirations. No recent options activity for ACRV as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how volatility skew is reported and how to read the data →